BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 30285867)

  • 21. Outcomes of Older Patients with Pulmonary Fibrosis and Non-Small Cell Lung Cancer.
    Whittaker Brown SA; Padilla M; Mhango G; Taioli E; Powell C; Wisnivesky J
    Ann Am Thorac Soc; 2019 Aug; 16(8):1034-1040. PubMed ID: 30990757
    [No Abstract]   [Full Text] [Related]  

  • 22. Acute exacerbations of fibrotic interstitial lung diseases.
    Suzuki A; Kondoh Y; Brown KK; Johkoh T; Kataoka K; Fukuoka J; Kimura T; Matsuda T; Yokoyama T; Fukihara J; Ando M; Tanaka T; Hashimoto N; Sakamoto K; Hasegawa Y
    Respirology; 2020 May; 25(5):525-534. PubMed ID: 31426125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
    Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
    Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and radiologic-pathological features of lung cancer in idiopathic pulmonary fibrosis.
    Liu Y; Zhu M; Geng J; Ban C; Zhang S; Chen W; Ren Y; He X; Chen W; Dai H
    Clin Respir J; 2018 Apr; 12(4):1700-1705. PubMed ID: 29094803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicoserological features of antisynthetase syndrome (ASyS)-associated interstitial lung disease presenting to respiratory services: comparison with idiopathic pulmonary fibrosis and ASyS diagnosed in rheumatology services.
    Barratt SL; Adamali HH; Cotton C; Mulhearn B; Iftikhar H; Pauling JD; Spencer L; Adamali HI; Gunawardena H
    BMJ Open Respir Res; 2021 Jan; 8(1):. PubMed ID: 33419741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases.
    Cheng JZ; Wilcox PG; Glaspole I; Corte TJ; Murphy D; Hague CJ; Ryerson CJ
    Respirology; 2017 Nov; 22(8):1592-1597. PubMed ID: 28544079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterizing Health Outcomes in Idiopathic Pulmonary Fibrosis using US Health Claims Data.
    Mortimer KM; Bartels DB; Hartmann N; Capapey J; Yang J; Gately R; Enger C
    Respiration; 2020; 99(2):108-118. PubMed ID: 31982886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: A single-center study from India.
    Singh P; Thakur B; Mohapatra AK; Padhan P
    Int J Rheum Dis; 2019 Sep; 22(9):1741-1745. PubMed ID: 31328423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pleuroparenchymal fibroelastosis as a histological background of autoimmune diseases.
    Kinoshita Y; Watanabe K; Ishii H; Kushima H; Hamasaki M; Fujita M; Nabeshima K
    Virchows Arch; 2019 Jan; 474(1):97-104. PubMed ID: 30327882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical profile of unclassifiable interstitial lung disease: Comparison with chronic fibrosing idiopathic interstitial pneumonias.
    Traila D; Oancea C; Tudorache E; Mladinescu OF; Timar B; Tudorache V
    J Int Med Res; 2018 Jan; 46(1):448-456. PubMed ID: 28758849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diffuse Pulmonary Ossification in Fibrosing Interstitial Lung Diseases: Prevalence and Associations.
    Egashira R; Jacob J; Kokosi MA; Brun AL; Rice A; Nicholson AG; Wells AU; Hansell DM
    Radiology; 2017 Jul; 284(1):255-263. PubMed ID: 28182861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors and outcomes in Japanese lung transplant candidates with interstitial lung disease.
    Ikezoe K; Handa T; Tanizawa K; Chen-Yoshikawa TF; Kubo T; Aoyama A; Motoyama H; Hijiya K; Tokuda S; Nakatsuka Y; Yamamoto Y; Oshima A; Harashima SI; Nagai S; Hirai T; Date H; Chin K
    PLoS One; 2017; 12(8):e0183171. PubMed ID: 28800589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis.
    Oda K; Yatera K; Fujino Y; Kido T; Hanaka T; Sennari K; Fushimi K; Matsuda S; Mukae H
    Respir Investig; 2018 Jan; 56(1):64-71. PubMed ID: 29325684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of idiopathic pulmonary fibrosis on advanced non-small cell lung cancer survival.
    Kanaji N; Tadokoro A; Kita N; Murota M; Ishii T; Takagi T; Watanabe N; Tojo Y; Harada S; Hasui Y; Kadowaki N; Bandoh S
    J Cancer Res Clin Oncol; 2016 Aug; 142(8):1855-65. PubMed ID: 27350261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Characteristics and Disease Course of Fibrosing Interstitial Lung Disease Patients in a Real-World Setting.
    Kilpeläinen M; Hirvonen T; Perkonoja K; Hirsjärvi S
    Medicina (Kaunas); 2023 Jan; 59(2):. PubMed ID: 36837481
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical characteristics in patients with asymmetric idiopathic pulmonary fibrosis.
    Callahan SJ; Xia M; Murray S; Flaherty KR
    Respir Med; 2016 Oct; 119():96-101. PubMed ID: 27692155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomarkers to identify ILD and predict lung function decline in scleroderma lung disease or idiopathic pulmonary fibrosis.
    Kennedy B; Branagan P; Moloney F; Haroon M; O'Connell OJ; O'Connor TM; O'Regan K; Harney S; Henry MT
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Sep; 32(3):228-36. PubMed ID: 26422568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of FDG-PET on the Detection of Patients with Lung Cancer at High Risk for ILD.
    Flechsig P; Hural O; Kreuter M; Eichhorn M; HEUßEL G; Sachpekidis C; Kauczor HU; Haberkorn U; Heussel CP; Eichinger M
    In Vivo; 2018; 32(6):1457-1462. PubMed ID: 30348701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trajectories and Prognostic Significance of 6-Minute Walk Test Parameters in Fibrotic Interstitial Lung Disease: A Multicenter Study.
    Khor YH; Farooqi M; Hambly N; Johannson KA; Marcoux V; Fisher JH; Assayag D; Manganas H; Khalil N; Kolb M; Ryerson CJ;
    Chest; 2023 Feb; 163(2):345-357. PubMed ID: 36089070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease.
    Natalini JG; Swigris JJ; Morisset J; Elicker BM; Jones KD; Fischer A; Collard HR; Lee JS
    Respir Med; 2017 Jun; 127():1-6. PubMed ID: 28502413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.